Safety and Immunogenicity of an Andes Virus DNA Vaccine by Needle-Free Injection: A Randomized, Controlled Phase 1 Study is a research paper published in The Journal of Infectious Diseases (2023). On theSindex it has a DataRank of 0.672. It has been cited 25 times, with 21 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.489
From this paper's citation signal
Citation Network Contribution
0.184
From 8 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 21 citers.
National Institutes of Health
Grant: HHSN272201300016I
National Institutes of Health
Grant: UM1AI148684
NIAID NIH HHS
Grant: UM1 AI148372
NIAID NIH HHS
Grant: HHSN272201300016C
National Institute of Allergy and Infectious Diseases
FWCI
4.34
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals